- Home»
- The Billing Beat Newsletter»
- BCBS Kansas – Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)
BCBS Kansas – Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)
October 1, 2022Medical Policy update :Revision 09-27-2022
Updated Description Section
Updated Rationale Section
Updated Coding Section ▪ Added 0338U (effective 10-01-2022)